HF
ABBV icon

HRT Financial’s AbbVie ABBV Stock Holding History

HRT Financial’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$177M Sell
702,907
-223,503
-24% -$48.1M 0.32% 38
2026
Q1 		$201M Buy
+926,410
New +$205M 0.5% 22
2025
Q4 		– Sell
-45,410
Closed -$10.3M – 3092
2025
Q3 		$10.5M Buy
45,410
+40,543
+833% +$8.26M 0.04% 382
2025
Q2 		$903K Sell
4,867
-66,056
-93% -$12.3M ﹤0.01% 1317
2025
Q1 		$14.9M Buy
70,923
+46,307
+188% +$9M 0.09% 161
2024
Q4 		$4.37M Sell
24,616
-281,029
-92% -$51.7M 0.02% 437
2024
Q3 		$60.4M Buy
305,645
+116,074
+61% +$21.7M 0.3% 36
2024
Q2 		$32.5M Buy
+189,571
New +$31.4M 0.18% 80
2024
Q1 		– Sell
-9,073
Closed -$1.41M – 2202
2023
Q4 		$1.41M Buy
+9,073
New +$1.32M 0.01% 822
2023
Q3 		– Sell
-192,074
Closed -$28.2M – 2315
2023
Q2 		$25.9M Buy
+192,074
New +$28.2M 0.24% 46
2022
Q3 		– Sell
-42,982
Closed -$6.17M – 2702
2022
Q2 		$6.58M Buy
+42,982
New +$6.57M 0.07% 200
2021
Q3 		– Sell
-136,812
Closed -$15.6M – 3213
2021
Q2 		$15.4M Buy
+136,812
New +$15.4M 0.14% 126
2020
Q1 		– Sell
-36,877
Closed -$3.27M – 714
2019
Q4 		$3.27M Buy
36,877
+27,319
+286% +$2.27M 0.14% 120
2019
Q3 		$723K Sell
9,558
-30,383
-76% -$2.08M 0.03% 489
2019
Q2 		$2.9M Buy
39,941
+36,996
+1,256% +$2.91M 0.18% 128
2019
Q1 		$237K Sell
2,945
-2,899
-50% -$237K 0.04% 346
2018
Q4 		$538K Buy
5,844
+2,414
+70% +$212K 0.08% 204
2018
Q3 		$324K Buy
3,430
+864
+34% +$81.9K 0.05% 237
2018
Q2 		$237K Buy
+2,566
New +$251K 0.09% 177
2015
Q1 		– Sell
-5,840
Closed -$382K – 67
2014
Q4 		$382K Buy
+5,840
New +$368K 0.54% 23

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

HRT Financial's ABBV Position: Q2 2026 in Review

HRT Financial reduced its AbbVie (ABBV) stake by 24% in Q2 2026, selling an estimated $48.1M and leaving 702,907 shares worth $177M. The position accounts for 0.32% of the portfolio, ranked #38.

HRT Financial first reported a position in ABBV in Q4 2014 and has held it in 20 quarters since. The position peaked at $201M in Q1 2026. 4,234 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • HRT Financial held 702,907 shares of AbbVie worth $177M as of Q2 2026.
  • HRT Financial sold 223,503 AbbVie shares in Q2 2026, an estimated $48.1M.
  • AbbVie made up 0.32% of HRT Financial's portfolio in Q2 2026, its #38 holding.
  • HRT Financial first reported a position in AbbVie in Q4 2014 and has held it in 20 quarters since.
  • HRT Financial's AbbVie position peaked at $201M in Q1 2026.
  • 4,234 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.